| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |